NASDAQ · OLPX

Olaplex Holdings, Inc.

$2.07 $0.00 (+0.00%) 1D

Key Metrics

$901.14M
Market cap
P/E · TTM
$2.39M
Revenue · TTM
−$5.75M
Net income
EPS · TTM $-0.01
Dividend yield
Free cash flow
Beta · 1Y 0.96
EBITDA · TTM
Gross margin 180.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 26
    The stock moved +51.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 26
  • Mar 13
    From its Mar 4 high, the share price fell 33%.

    Peak close $1.78 on Mar 4; trough close $1.20 on Mar 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%
  • Mar 4
    The stock moved +18.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$901.14M
Enterprise value$927.46M
Shares outstanding667.5M
52-wk range$0.99 – $2.09
Avg volume · 20D2.5M
Net cash −$26.32M
Book value / share$1.32
IndustryPerfumes, Cosmetics & Other Toilet Preparations
ExchangeNASDAQ
About Olaplex Holdings, Inc.
IPO dateSep 30, 2021
Employees231

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S376.89
P/FCF
EV/EBITDA
EV/Sales387.89
Graham №

Profitability

Gross 180.0%
Operating -441.8%
Net -240.6%
FCF
ROE / ROIC -0.7% · —

Financial Health

Current ratio6.27
Quick ratio5.34
Debt / equity0.40
Debt / EBITDA
Net cash −$26.32M
Working capital$375.11M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings